Approval of psychedelic therapy by the FDA could benefit over 5 million Americans. New findings indicate that 56-62% of people being treated for Major Depressive Disorder and Treatment-Resistant Depression (5.1-5.6 million people) would be eligible and benefit from psilocybin-assisted therapy.
Read Full Article
#PsychedelicTherapy #MentalHealthAwareness #Psilocybin #FDAApproval #DepressionRecovery
Read Full Article
#PsychedelicTherapy #MentalHealthAwareness #Psilocybin #FDAApproval #DepressionRecovery
Technology Networks
Approval of Psychedelic Therapy Could Benefit Over 5 Million Americans
A new study has demonstrated the potential impact of psilocybin-assisted therapy on people with depression, if approved by the FDA.
👍4😢1
US FDA approves suzetrigine, the first non-opioid painkiller in decades, that delivers opioid-level pain suppression without the risks of addiction, sedation or overdose. A new study outlines its pharmacology and mechanism of action.
Read Full Article
#Suzetrigine #PainRelief #NonOpioid #FDAApproval #Pharmacology
Read Full Article
#Suzetrigine #PainRelief #NonOpioid #FDAApproval #Pharmacology
Nature
US drug agency approves potent painkiller — the first non-opioid in decades
Nature - The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
👍4🦄1
FDA Approves First Pig Kidney Transplant Trials, Offering Hope for Organ Shortage
Read Full Article
#KidneyTransplant #OrganShortage #FDAApproval #MedicalInnovation #Xenotransplantation
Read Full Article
#KidneyTransplant #OrganShortage #FDAApproval #MedicalInnovation #Xenotransplantation
🔥3🤔1🤮1
A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in over two decades.
Read Full Article
#NonOpioid #PainRelief #Suzetrigine #FDAApproval #HealthInnovation
Read Full Article
#NonOpioid #PainRelief #Suzetrigine #FDAApproval #HealthInnovation
ScienceAlert
New Non-Opioid Painkiller First in Decades to Win FDA Approval
A game changer.
👍2
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease 🩸🧠💉
Read Full Article
#AlzheimersAwareness #FDAApproval #BloodTestBreakthrough #HealthInnovation #NeurologyNews
Read Full Article
#AlzheimersAwareness #FDAApproval #BloodTestBreakthrough #HealthInnovation #NeurologyNews
U.S. Food and Drug Administration
FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
The U.S. Food and Drug Administration cleared for marketing the first in vitro diagnostic device that tests blood, to aid in diagnosing Alzheimer’s disease.
Tissium’s polymer solution set to transform nerve repair after FDA nod 🧠✨💉
Read Full Article
#Tissium #NerveRepair #MedicalInnovation #FDAApproval #Biotechnology
Read Full Article
#Tissium #NerveRepair #MedicalInnovation #FDAApproval #Biotechnology
Two years ago, FDA approved sale of over-the-counter birth control pill for first time in US without a prescription. This has dramatically improved access to contraception, especially for women who would have had no birth control at all because they lack insurance or routine access to health care. 💊🇺🇸✨
Read Full Article
#BirthControlAccess #FDAApproval #WomenHealth #ReproductiveRights #OverTheCounterContraceptives
Read Full Article
#BirthControlAccess #FDAApproval #WomenHealth #ReproductiveRights #OverTheCounterContraceptives
OHSU News
Over-the-counter pill boosts access to contraception, OHSU study finds
Nationwide study documents 31% percentage point increase in people shifting from no birth control to the over-the-counter oral contraceptive.
🤷♂2❤1👏1🤡1
Tofersen, a new drug approved by the FDA for a genetic form of ALS, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement. “Stopping disease progression and making improvements over 3 to 5 years is unheard of in this type of ALS.” 🧬💊⏳
Read Full Article
#Tofersen #ALSDisease #FDAApproval #MedicalBreakthrough #HopeForPatients
Read Full Article
#Tofersen #ALSDisease #FDAApproval #MedicalBreakthrough #HopeForPatients
WashU Medicine
New ALS drug stabilizes decline with improved strength, mobility for some | WashU Medicine
Long-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS